Botox in dermatology
2001; Wiley; Volume: 40; Issue: 5 Linguagem: Italiano
10.1046/j.1365-4362.2001.01176.x
ISSN1365-4632
AutoresHassan Abbas Khawaja, Enríque Hernández-Pérez,
Tópico(s)Facial Rejuvenation and Surgery Techniques
ResumoInternational Journal of DermatologyVolume 40, Issue 5 p. 311-317 Botox in dermatology Hassan Abbas Khawaja MD, Hassan Abbas Khawaja MD Center for Dermatology and Cosmetic Surgery, San Salvador, El SalvadorSearch for more papers by this authorEnrique Hernandez-Perez MD, Enrique Hernandez-Perez MD Center for Dermatology and Cosmetic Surgery, San Salvador, El SalvadorSearch for more papers by this author Hassan Abbas Khawaja MD, Hassan Abbas Khawaja MD Center for Dermatology and Cosmetic Surgery, San Salvador, El SalvadorSearch for more papers by this authorEnrique Hernandez-Perez MD, Enrique Hernandez-Perez MD Center for Dermatology and Cosmetic Surgery, San Salvador, El SalvadorSearch for more papers by this author First published: 21 December 2001 https://doi.org/10.1046/j.1365-4362.2001.01176.xCitations: 13 , Enrique Hernandez-Perez, md, Club Vip No. 369, PO Box 525364, Miami, FL 33152. E-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Carruthers, J & Carruthers, A. Treatment of glabellar frown lines with C. botulinum A exotoxin. J Dermatol Surg Oncol 1992; 18, 17–21. 2 Hernández-Pérez, E. Resorcinol peels as a part of a facial rejuvenation program. Am J Cosmetic Surg 1997; 14, 275–280. 3 Hernández-Pérez, E. Different grades of chemical peels. Am J Cosmetic Surg 1990; 7, 67–70. 4 Hernández-Pérez, E & Carpio, E. Resorcinol peels; gross and microscopic study. Am J Cosmetic Surg 1995; 12, 337–340. 5 Kligman, AG, Grove, GL, Hirose, R, Leyden, J. Topical tretinoin for photoaged skin. J Am Acad Dermatol 1986; 15, 836. 6 Weiss, JS, Ellis, CN, Headington, JT et al. Topical tretinoin improves photoaged skin. JAMA 1998; 116, 259–527. 7 Weiss, JS, Ellis, CN, Headington, JT, Voorhees, JJ. Topical tretinoin in the treatment of ageing skin. J Am Acad Dermatol 1988; 19, 169. 8 Hernández-Pérez, E, Henriquez, A, Marroquin Burgos, R. Isotretinoin en el acne vulgar. Experiencia en 4,000 casos. Dermatol Rev Mex 1994; 38, 263–266. 9 Lassus, C. Expanded PTFE in the treatment of facial wrinkles. Aesthetic Plast Surg 1991; 15, 167–174. 10 Walman, SR. Gore-tex for augmentation of the nasal dorsum. A preliminary report. Ann Plast Surg 1991; 26, 520–525. 11 Schoenrock, LD & Repucci, AD. Gore-tex in facial plastic surgery. Int J Aesthetic Restor Surg 1993; 1, 63–68. 12 Lassus, C. A surgical solution to the deep nasolabial fold. Plast Reconstr Surg 1996; 97, 1473–1478. 13 Hernández-Pérez, E. Bilevel lipoinjection for facial wrinkles. Am J Cosmetic Surg 1992; 4, 73–75. 14 Hernández-Pérez, E. Implantes de grasa autologa. In: F Camacho & F Dulanto, eds. Lipoimplante. Cirugia Dermatologica Madrid: Biblioteca Aula Medica, 1995: 563–569. 15 Carruthers, A & Carruthers, JDA. The use of botulinum toxin to treat glabellar frown lines and other facial wrinkles. Cosmet Dermatol 1994; 75, 11–15. 16 Carruthers, JA & Carruthers, JDA. Aesthetic indications for botulinum toxin injections (Letter). Plast Reconstr Surg 1995; 95, 427–428. 17 Botox Mixing Instructions., Technical Video Tape. & Irvine, CA. Allergan–Herbert Pharmaceuticals., 1994. 18 Gartland, MG & Hoffman, HT. Crystalline preparation of botulinum toxin type A (Botox): degradation in potency with storage. Otolaryngol Head Neck Surg 1993; 108, 135–140. 19 Coleman, WP, Hanke, CW, Alt, TH. Cosmetic Surgery of the Skin. 2nd edn. St Louis, Missouri. Mosby Year Book Inc., 1997: 231–235. 20 Garcia, A & Fulton, E. Cosmetic denervation of the muscles of facial expression with botulinum toxin. Dermatol Surg 1996; 22, 39–43.DOI: 10.1016/1076-0512(95)00464-5 21 Guyuron, B & Huddleston, SW. Aesthetic indication for botulinum toxin injection. Plast Reconstr Surg 1994; 93, 913–918. 22 Carruthers, A, Carruthers, J, Kiena, K. Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol 1996; 34, 788–795. 23 Keen, M, Blitzer, A, Aviv, J et al. Botulinum toxin A for hyperkinetic facial lines. Results of a double blind, placebo-controlled study. Plast Reconstr Surg 1994; 94, 94–99. 24 Brooks, GF, Butel, JS, Ornston, LN. Jawetz, Melnick and Adelbergs Medical Microbiology. 20th edn. Connecticut: Appleton and Lange., 1995: 174–176. 25 Ganong, WF. Review of Medical Physiology. 16th edn. East Norwalk, Connecticut: Appleton and Lange., 1993: 99–102. 26 Walter, JB & Israel, MS. General Pathology. 6th edn. New York. Churchill Livingstone., 1987: 155–159. 27 Bushara, KO, Park, KM, Jones, JC, Schutta, HS. Botulinum toxin. A possible new treatment for axillary hyperhidrosis. Clin Exp Dermatol 1996; 21, 276–278. 28 Naumann, M, Flachenecker, P, Brocher, EB et al. Botulinum toxin for palmar hyperhidrosis. Lancet 1997; 1, 252. 29 Schnider, P, Binder, M, Berger, T, Auff, E. Botulinum toxin injection in focal hyperhidrosis. Br J Dermatol 1996; 134, 1160–1161. 30 Tsui, JK, Wong, NLM, Wong, E, Calne, DB. Production of circulating antibodies to botulinum A toxin in patients receiving repeated injection for dystonia (Abstract). Ann Neurol 1988; 23, 181. 31 Circin, RL & Barek, D. Complications of injectable collagen implant. Plast Reconstr Surg 1983; 71, 731. 32 Klein, AW. Cosmetic therapy with botulinum toxin. Anecdotal memoirs. Dermatol Surg 1996; 22, 757–759.DOI: 10.1016/s1076-0512(96)00341-x 33 Pierard, GE & Lapiera, CM. The micro-anatomical basis of facial frown lines. Arch Dermatol 1989; 125, 1090–1092. 34 Salasche, SJ & Bernstein, G. Surgical Anatomy of the Skin. 1st edn. Connecticut: Appleton and Lange., 1988: 99–139. 35 Keen, M, Kopelman, J, Reed, M et al. Botulinum toxin A. A novel method to remove periorbital wrinkles. Facial Plast Surg 1994; 10, 141–146. 36 Driezen, NG & Framn, L. Sudden unilateral visual loss after autologous fat injection into the glabellar area. Am J Ophthalmol 1989; 107, 85–86. 37 Teimourian, B. Blindness following fat injection. Plast Reconstr Surg 1988; 92, 361. 38 Carruthers, J, Carruthers, A, Bagaric, D. Can ptosis incidence be reduced after lid injections for blepharospasm and hemifacial spasm? (Letter). Can J Ophthalmol 1995; 30, 147. 39 Carruthers, JDA & Stubbs, HA. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age related lower eyelid entropion. Can J Neurol Sci 1987; 14, 42–45. 40 Botox. Product Information Sheet. Irvine, CA. Allergan–Herbert Pharmaceuticals., 1996. 41 Borodic, GE, Cheney, M, McKenna, M. Contralateral injections of botulinum A toxin for the treatment of hemifacial spasm to achieve increased facial symmetry. Plast Reconstr Surg 1992; 90, 972–977. 42 Clark, RP & Berris, CE. Botulinum toxin. A treatment for facial asymmetry caused by facial nerve paralysis. Plast Reconstr Surg 1989; 84, 353–355. 43 Erbguth, F, Claus, D, Engelhardt, A et al. Systemic effect of botulinum toxin injections unmasks subclinical Lambert–Eaton myasthenic syndrome (letter). J Neurol Neurosurg Psychiatr 1993; 56, 1235–1236. Citing Literature Volume40, Issue5May 2001Pages 311-317 ReferencesRelatedInformation
Referência(s)